Benzamide derivatives as EP4 receptor agonists

Details for Australian Patent Application No. 2007331471 (hide)

Owner Glaxo Group Limited

Inventors Swarbrick, Martin Edward; Johnson, Christopher Norbert; Gaiba, Alessandra; Stanway, Steven James; Roomans, Susan; Healy, Mark Patrick

Agent Davies Collison Cave

Pub. Number AU-A-2007331471

PCT Pub. Number WO2008/071736

Priority 0715145.9 03.08.07 GB; 0625098.9 15.12.06 GB

Filing date 12 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 235/56 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/071736 Priority application(s): WO2008/071736

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331473-Selective inhibitors of neurotensin degrading enzymes

2007331463-Antibodies against human cytomegalovirus (hCMV)